MEDXT
MEDXT
Fundamental comparison between MEDXT and Pepe
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
MEDXT
Pepe
Detailed Comparison
| Metric | MEDXT | Pepe |
|---|---|---|
| Price | $0.000696 | $0.000003 |
| Market Cap | $14.48M | $1.20B |
| 24h Volume | 3.2K | 130.6M |
| Rank | #951 | #60 |
| Circulating Supply | 20.8B | 420.7T |
| ATH | $0.003421 | $0.000028 |
MEDXT vs Pepe — Analysis
MEDXT and Pepe are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 13 fundamental market, supply, capital and developer metrics.
Value Score Comparison
With a Value Score of 58, MEDXT is currently rated as "fair value", while Pepe scores 76.6 and is rated "undervalued". This means our algorithm considers Pepe the fundamentally stronger investment.
Market Cap & Risk
Pepe has a 83x larger market capitalization than MEDXT. A larger market cap typically means less volatility but also less growth potential. MEDXT may offer more upside but comes with higher risk.
Price Performance
Over the last 24 hours, MEDXT moved -10.50%, while Pepe changed -0.10%. Looking at the 7-day window, MEDXT is at 112.20% and Pepe at 3.30%.
Distance from All-Time High
MEDXT currently trades at 20% of its all-time high ($0.003421), while Pepe sits at 10% of its ATH ($0.000028). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.
Conclusion
Based on our fundamental analysis, Pepe (Score: 76.6) currently has a stronger investment case than MEDXT (Score: 58). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.